Thermo Fisher Scientific
TMO
1,678 hedge funds and large institutions have $116B invested in Thermo Fisher Scientific in 2019 Q4 according to their latest regulatory filings, with 220 funds opening new positions, 538 increasing their positions, 671 reducing their positions, and 62 closing their positions.
255% more first-time investments, than exits
New positions opened: 220 | Existing positions closed: 62
11% more capital invested
Capital invested by funds: $105B → $116B (+$11.3B)
9% more funds holding
Funds holding: 1,544 → 1,678 (+134)
6% more funds holding in top 10
Funds holding in top 10: 133 → 141 (+8)
0.65% less ownership
Funds ownership: 89.74% → 89.09% (-0.65%)
14% less call options, than puts
Call options by funds: $386M | Put options by funds: $451M
20% less repeat investments, than reductions
Existing positions increased: 538 | Existing positions reduced: 671
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$392M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$259M |
| 3 |
ECU
Egerton Capital (UK)
London,
United Kingdom
|
+$188M |
| 4 |
Korea Investment Corp
Seoul,
South Korea
|
+$148M |
| 5 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$117M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$234M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$212M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$155M |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$139M |
| 5 |
EC
Eminence Capital
New York
|
-$138M |
TMO Hedge Fund Activity: Q4 2019 in Review
1,678 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2019, worth a combined $116B — up 11% from $105B a quarter earlier.
Buyers outnumbered sellers: 220 funds opened new TMO positions and 62 closed out — a net gain of 158 holders — while 538 added to existing stakes and 671 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $392M. The largest seller was T. Rowe Price Associates, cutting an estimated $234M.
- 1,678 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2019, up from 1,544 in Q3 2019.
- Funds reported $116B of Thermo Fisher Scientific stock for Q4 2019, up 11% quarter-over-quarter.
- 220 funds opened new Thermo Fisher Scientific positions in Q4 2019 and 62 closed out, a net change of +158 holders.
- The largest Thermo Fisher Scientific buyer in Q4 2019 was Morgan Stanley, an estimated $392M added.
- The largest Thermo Fisher Scientific seller in Q4 2019 was T. Rowe Price Associates, an estimated $234M sold.
Based on aggregated 13F filings for Q4 2019.